Tag Archives: USPTO

Genetic Technologies v. LabCorp. – Mayo Redux.

Posted on September 16, 2014 by Warren Woessner

It was Mayo redux with a vengeance in the September 23, 2014 decision in Genetic Technologies Ltd. v. Laboratory Corp. of Amer. Holdings et al., Civil Action No. 12-1736-LPS-CJB (D. Del. 2014).  Magistrate Judge Burke released an opinion invalidating claim … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | 2 Comments

101 Rejections Under the Guidelines: Mayo and Myriad “Go Viral”

Posted on September 4, 2014 by Warren Woessner

This is a guest post from Hans Sauer, Deputy General Counsel, Intellectual Property for BIO. “Recently, I set out to find real-world examples of recent rejections under the USPTO Guidance, to do my own sampling rather than rely on reported … Continue reading →

Posted in Claim Interpretation | Tagged , , , , , , , , , , , , | 1 Comment

Takeaways from Seattle Summer 2014 Seminars

Posted on August 25, 2014 by Warren Woessner

A guest post by Donald Chisum and Janice Mueller. In August 2014 the Chisum Patent Academy held two back-to-back seminars in its Seattle, Washington facility to discuss and debate current developments in patent law. Each roundtable seminar group was limited … Continue reading →

Posted in Conferences and Classes | Tagged , , , , , , | Leave a comment

USPTO TRIPs over Myriad-Mayo guidance

Posted on July 31, 2014 by Warren Woessner

Timothy W. Roberts, Chartered Patent Attorney; MA (Oxon); LL.D (honoris causa, Sheffield University) Paul G. Cole,  Chartered Patent Attorney;  MA (Oxon); LLM, NottinghamTrent; Visiting Professor, Bournemouth University The above UK-based European Practitioners have today filed comments at the USPTO arguing … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 1 Comment